Skip to content

mHealth Technologies for Hearing Aid Users

The Feasibility of mHealth Technologies to Improve Hearing Aid Use and Benefit in First-time Hearing Aid Users

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03136718
Acronym
m2Hear
Enrollment
94
Registered
2017-05-02
Start date
2017-04-01
Completion date
2018-10-24
Last updated
2019-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss

Keywords

mHealth, Hearing aids, Auditory rehabilitation, Adult, Reusable Learning Object, Education, Personalised, Telehealth, Teleaudiology

Brief summary

This study will establish the feasibility of a theoretically-driven, personalised educational intervention delivered through mobile technologies in first-time hearing aid users. Namely, the C2Hear (https://www.youtube.com/C2HearOnline) multimedia videos, or Reusable Learning Objects (RLOs) (Ferguson et al., 2015; 2016), will be repurposed into short 'bite-sized' mobile-enabled RLOs (mRLOs).The development of the intervention will be based on a recently developed comprehensive model of health behaviour change (COM-B) (Michie et al., 2014). The intervention will be tailored to individuals' needs, and incorporate greater user interactivity and self-evaluation.

Detailed description

Research question: Is it feasible for first-time hearing aid users to use a personalised educational intervention delivered through mobile technologies in their everyday life? Objectives: To establish the feasibility of the intervention by evaluating delivery, accessibility, usability, acceptability, and adherence in first-time hearing aid users. To establish suitable outcome measures to evaluate the effectiveness of the intervention in a future randomised controlled trial. Study Design: Single centre, feasibility. Naïve first-time hearing aid users will try out the intervention away from the laboratory. Following 10-12 weeks of independent use, the investigators will assess how the participants used the intervention using a mixed-methods approach across two parallel stages: Stage 1. The investigators will assess the feasibility of the intervention in first-time hearing aid users, who will be invited to take part in semi-structured interviews. Using the COM-B model (Michie et al., 2014) as the framework underpinning the interviews, delivery, accessibility, usability, acceptability, and adherence of the intervention will be evaluated. Transcribed audio-recordings will be analysed using thematic analysis (Braun & Clarke, 2006). A total of 15 participants is typically sufficient to achieve data saturation (the point in data collection when no new information emerges) using this qualitative methodology (Guest et al., 2006). To allow for 18% attrition (Ferguson et al., 2016), 18 patients will be. To prevent potential confounding of the interviews, participants will not be required to complete quantitative outcome measures used in stage 2. Stage 2. The investigators will assess which outcome measures are suitable to assess the intervention in terms how well it supported users to make changes to their behaviour. First-time hearing aid users will complete outcome measures by interview. Outcomes were selected based on the World Health Organisation's International Classification of Functioning, Disability and Health (ICF) (WHO, 2001), which provides a theoretical framework upon which to measure the success of amplification using hearing aids. At least 50 participants are required to allow for sufficient between- and within-subject variability in order to calculate important change scores for each outcome measure. To allow for 18% attrition 59 patients will be recruited.

Interventions

OTHERMobile-enabled RLOs (mRLOs)

A theoretically-driven, personalised educational intervention delivered through mobile technologies based on the C2Hear (https://www.youtube.com/C2HearOnline) RLOs. The mRLO intervention will include shorter 'bite-sized' RLOs suitable for mobile technologies. This will allow a unique dynamic tailoring approach, whereby relevant mRLOs will be provided based on the user's responses to a self-evaluation filter aid, which will enable individualised, tailored learning.

Sponsors

University of Nottingham
CollaboratorOTHER
Nottingham University Hospitals NHS Trust
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* First-time hearing aid users (or if previous users, but not having worn hearing aids for more than 3 years) * Familiar with mobile technologies (e.g. owns a smartphone or tablet device, or uses one regularly) * English as a first spoken language or a good understanding of English. It is important that participants can understand the content of the resources and work with the interactive elements, as well as be able to answer outcome questionnaires, to ensure valid data are collected.

Exclusion criteria

* Unable to complete the questionnaires without assistance due to age-related problems (e.g. cognitive decline or dementia), to ensure valid data are collected.

Design outcomes

Primary

MeasureTime frameDescription
Glasgow Hearing Aid Benefit Profile (GHABP: Gatehouse, 1999) - Hearing aid useFollowing 10-12 weeks of independent use of the mRLO interventionSelf-reported hearing aid use measured on a five-point scale.

Secondary

MeasureTime frameDescription
Hearing aid dataloggingFollowing 10-12 weeks of independent use of the mRLO interventionHearing aid use in hours internal to the hearing aid
Glasgow Hearing Aid Benefit Profile (GHABP)Baseline (Part I) and following 10-12 weeks of independent use of the mRLO intervention (Part II)Assesses hearing disability (or activity limitations) and handicap (or participation restrictions; part 1), and hearing aid use, benefit, residual disability and satisfaction (part 2). Each domain is measured on a five-point scale.
Hearing Handicap Inventory for the Elderly (HHIE: Ventry & Weinstein, 1982)Baseline and following 10-12 weeks of independent use of the mRLO intervention25-item questionnaire designed to assess the effects of hearing loss on the emotional (n = 13), and social/situational adjustment (n = 12) of older people, scored using a three-point scale (4 = yes; 2 = sometimes; 0 = no).
Social Participation Restrictions Questionnaire (SPaRQ: Heffernan et al., 2015)Baseline and following 10-12 weeks of independent use of the mRLO interventionA 19-item inventory that assesses social behaviors (9-items) and perceptions (10-items) in adults with mild-to moderate hearing loss. Each item is measured on an 11-point response scale ranging from 'Completely Disagree' at point zero to 'Completely Agree' at point ten.
Hearing Aid and Communication Knowledge (HACK: Ferguson et al., 2015)Baseline and following 10-12 weeks of independent use of the mRLO interventionA 20-item open-ended questionnaire that measures free recall of knowledge relevant to practical (n = 12) and psychosocial (n = 8) issues on hearing aids and communication.
Clinical Global Impression Scale - Hearing difficultiesBaseline and following 10-12 weeks of independent use of the mRLO interventionA one item questionnaire to be used to identify the minimal important change score specific to each self-reported outcome measure.
Wechsler Adult Intelligence Scale (WAIS) - Digit Span (Wechsler, 1997)Baseline and following 10-12 weeks of independent use of the mRLO interventionCognitive measure of memory recall
Measure of Audiologic Rehabilitation Self-efficacy for Hearing Aids (MARS-HA: West & Smith, 2007)Baseline and following 10-12 weeks of independent use of the mRLO interventionIncludes four subscales: basic handling, advanced handling, adjustment to hearing aids, and aided listening skills. Respondents indicate how confident they are that they could do the things described on an 11-point scale (0%=cannot do this, to 100%=certain I can do this).

Other

MeasureTime frameDescription
Adverse effects12 weeksAdverse effects arising from the intervention

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026